Pharmafile Logo
Pharmafocus logo
Advanced Search

Manufacturing and Production

Showing 15 posts of 5860 posts found.

131 confirmed cases of monkeypox reported in 19 countries

May 24, 2022 Manufacturing and Production

UK officials have warned that monkeypox could turn into a Europe-wide endemic if pets catch the virus. This could also …
News

Regeneron treatment fights ultra-rare form of high cholesterol in children

May 24, 2022 Manufacturing and Production

Regeneron has shared positive results from its Phase III trial of a candidate drug, for children with a rare, life-threatening …
News

Study launched to investigate COVID-19 vaccine in young immunocompromised

May 17, 2022 Manufacturing and Production

The UK’s largest kidney research charity has announced the launch of a study into the protection offered by COVID-19 vaccines …
News

WHO delivers 20 ambulances to Ukraine

May 10, 2022 Manufacturing and Production

In efforts to support emergency health needs in Ukraine, WHO have given 20 all-terrain ambulances able to function in even …
News

MGC Pharma receives patent protection for epilepsy drug

May 10, 2022 Manufacturing and Production

MGC Pharmaceuticals said a patent had been granted, protecting its unique system used to deliver a cannabis-derived drug being developed …
News

Fourth-dose COVID-19 jab demonstrates good boost

May 10, 2022 Manufacturing and Production

A UK trial has revealed that fourth-dose COVID-19 booster vaccines increase protection against the disease, particularly those aged over 70. …
News

NIH discovery could advance precise therapies for blinding diseases

May 10, 2022 Manufacturing and Production

Research at the National Institutes of Health (NIH) have identified distinct differences among the cells comprising a tissue in the …
News

Jyseleca recommended by HSE for treatment of ulcerative colitis in Ireland

May 3, 2022 Manufacturing and Production

Galapagos Biotech LTD has announced that further to approval from the Health Service Executive (HSE), eligible patients in Ireland will …
News

EU plans to cut unneeded medical tests with data health plan

May 3, 2022 Manufacturing and Production

The EC has announced plans to make health data easier to access for patients, medics, regulators, and researchers, to improve …
News

FDA approve first nonstimulant ADHD med for adults in two decades

May 3, 2022 Manufacturing and Production

The FDA has expanded the indication of Supernus’s Qelbree to patients aged 18 and older, marking the drug as the …
News

EC approves Cabotemyx as second-line treatment for thyroid cancer patients

May 3, 2022 Manufacturing and Production

The EC has approved the use of Cabotemyx (cabozantinib) as a monotherapy for the treatment of adult patients with locally …
News

UK study finds raising frequency of COPD flare ups increases risk of death

April 26, 2022 Manufacturing and Production

The EXACOS UK study in Chronic Obstructive Pulmonary Disease (COPD), funded by AstraZeneca, has shown that an increasing frequency of …
News

FDA approves first COVID-19 treatment for young children

April 26, 2022 Manufacturing and Production

The FDA has expanded the approval of the COVID-19 treatment, Veklury (remdesivir), to include pediatric patients 28 days of age …
News

AstraZeneca drug granted FDA Priority Review

April 19, 2022 Manufacturing and Production

AstraZeneca and Daiichi Sankyo have announced that the lung cancer antibody drug conjugate, Enhertu, has received Priority Review from the …
News

FDA accept New Drug Application for GSK’s daprodustat

April 19, 2022 Manufacturing and Production

GSK has announced the FDA has accepted the New Drug Application (NDA) for daprodustat, an oral hypoxia-inducible factor prolyl hydroxylase …
News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026